Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
42.41
Dollar change
-2.61
Percentage change
-5.80
%
Index- P/E- EPS (ttm)-2.68 Insider Own38.43% Shs Outstand31.68M Perf Week-6.91%
Market Cap1.54B Forward P/E- EPS next Y-1.80 Insider Trans-7.53% Shs Float22.42M Perf Month-6.19%
Income-52.03M PEG- EPS next Q-0.59 Inst Own58.09% Short Float15.18% Perf Quarter-2.42%
Sales0.00M P/S- EPS this Y-1.15% Inst Trans-0.92% Short Ratio8.23 Perf Half Y9.96%
Book/sh4.30 P/B9.86 EPS next Y24.54% ROA-55.24% Short Interest3.40M Perf Year661.40%
Cash/sh4.11 P/C10.32 EPS next 5Y15.00% ROE-71.26% 52W Range3.69 - 53.82 Perf YTD5.37%
Dividend Est.- P/FCF- EPS past 5Y24.34% ROI-36.28% 52W High-21.20% Beta-1.38
Dividend TTM- Quick Ratio11.23 Sales past 5Y0.00% Gross Margin- 52W Low1049.32% ATR (14)2.55
Dividend Ex-Date- Current Ratio11.23 EPS Y/Y TTM12.46% Oper. Margin0.00% RSI (14)45.28 Volatility5.92% 5.42%
Employees42 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.14 Target Price67.29
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q33.18% Payout- Rel Volume0.95 Prev Close45.02
Sales Surprise- EPS Surprise-60.72% Sales Q/Q- EarningsMay 09 AMC Avg Volume413.24K Price42.41
SMA20-3.58% SMA50-0.67% SMA20021.18% Trades Volume390,680 Change-5.80%
Date Action Analyst Rating Change Price Target Change
May-10-24Initiated Robert W. Baird Outperform $72
Feb-05-24Initiated Piper Sandler Overweight $93
Jan-23-24Initiated Stifel Buy $63
Nov-21-23Resumed Guggenheim Buy $40
Sep-29-20Initiated Guggenheim Buy $8
Jan-10-20Initiated Craig Hallum Buy $8
Dec-23-19Initiated Oppenheimer Outperform $10
Feb-13-18Reiterated Maxim Group Buy $8 → $4
Jun-04-24 08:00AM
May-22-24 04:05PM
08:00AM
May-15-24 08:00AM
02:22AM
07:16AM Loading…
May-10-24 07:16AM
May-09-24 11:54PM
04:05PM
May-03-24 05:46AM
May-02-24 10:32PM
04:01PM
Apr-30-24 08:00AM
Apr-29-24 11:12AM
11:11AM
08:00AM
04:05PM Loading…
Apr-19-24 04:05PM
Apr-04-24 01:54AM
01:54AM
Mar-08-24 04:05PM
Mar-06-24 10:53PM
04:05PM
Feb-22-24 08:00AM
Feb-14-24 08:50AM
Feb-05-24 10:10AM
Feb-01-24 08:00AM
Jan-29-24 04:05PM
Jan-26-24 08:50AM
Jan-24-24 08:00AM
Jan-10-24 08:50AM
Jan-05-24 08:00AM
06:59PM Loading…
Dec-21-23 06:59PM
Dec-15-23 09:30AM
Dec-14-23 03:44PM
03:05PM
07:00AM
Dec-01-23 03:06AM
Nov-27-23 01:02PM
Nov-20-23 03:06PM
Nov-10-23 04:05PM
Nov-07-23 08:00AM
Nov-06-23 08:00AM
Nov-01-23 11:30AM
Oct-26-23 10:33AM
Oct-20-23 01:22PM
Oct-16-23 04:07PM
08:01AM
Oct-06-23 06:25PM
Oct-04-23 06:16PM
04:05PM
Oct-03-23 08:00AM
Oct-02-23 04:05PM
Sep-28-23 09:58AM
08:30AM
Sep-27-23 06:08PM
04:55PM
04:01PM
03:30PM
01:28PM
07:21AM
Sep-26-23 04:11PM
12:51PM
12:17PM
07:30AM
Sep-25-23 08:00AM
Aug-18-23 09:02PM
Aug-16-23 08:00AM
Aug-08-23 04:05PM
Jun-02-23 06:35PM
May-09-23 04:05PM
May-03-23 04:05PM
Apr-26-23 06:50AM
Mar-28-23 08:00AM
Mar-21-23 04:05PM
Mar-16-23 06:33AM
Mar-07-23 08:00AM
Feb-01-23 04:25PM
Jan-26-23 08:00AM
Jan-13-23 12:00PM
Dec-19-22 08:00AM
Nov-09-22 04:05PM
Oct-10-22 11:23AM
Oct-03-22 08:00AM
Sep-30-22 11:47AM
Sep-29-22 11:42AM
Sep-22-22 10:57AM
Sep-20-22 12:04PM
Sep-12-22 11:26AM
Sep-07-22 10:02AM
Sep-06-22 08:00AM
Aug-18-22 11:04AM
Aug-10-22 04:05PM
Jul-20-22 10:59AM
08:00AM
Jul-11-22 04:05PM
Jul-07-22 09:36AM
08:39AM
Jul-06-22 09:32AM
Jun-14-22 05:56AM
Jun-13-22 04:05PM
Jun-07-22 08:00AM
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vivo Opportunity, LLC10% OwnerApr 30 '24Sale45.13351,24215,851,5517,316,851May 01 01:10 PM
Vivo Opportunity, LLC10% OwnerApr 29 '24Sale47.80750,00035,850,0007,668,093May 01 01:10 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERApr 01 '24Sale41.3418,980784,645152,790Apr 03 09:36 PM
Mackaness James HCHIEF FINANCIAL OFFICERApr 01 '24Sale41.345,175213,93762,953Apr 03 09:39 PM
Yen KristenSEE REMARKSApr 01 '24Sale41.342,21891,69423,422Apr 03 09:40 PM
Hirano Patricia CSEE REMARKSApr 01 '24Sale41.342,21891,69441,812Apr 03 09:37 PM
Anish BhatnagarCHIEF EXECUTIVE OFFICERJan 25 '24Sale48.302,527122,054171,770Jan 29 05:42 PM
Hirano Patricia CSEE REMARKSJan 25 '24Sale48.3083240,18643,142Jan 29 05:44 PM
Yen KristenSEE REMARKSJan 25 '24Sale48.3039719,17525,640Jan 29 05:47 PM
Hirano Patricia CSee RemarksDec 14 '23Sale36.491,35949,58419,974Dec 15 06:00 PM
Yen KristenSee RemarksDec 13 '23Option Exercise2.5517,91645,64419,953Dec 14 07:57 PM
Yen KristenSee RemarksDec 13 '23Sale37.7617,916676,5572,037Dec 14 07:57 PM
Hirano Patricia CSee RemarksDec 13 '23Sale38.794,885189,51321,333Dec 15 06:00 PM
Yen KristenSee RemarksDec 12 '23Sale36.9519,913735,8742,037Dec 14 07:57 PM
Mackaness James HChief Financial OfficerDec 11 '23Option Exercise2.6015,00038,92544,610Dec 13 09:34 PM
Anish BhatnagarChief Executive OfficerDec 11 '23Sale35.6793,4083,331,70124,297Dec 13 09:34 PM
Mackaness James HChief Financial OfficerDec 11 '23Sale36.4132,4821,182,82812,128Dec 13 09:34 PM
Anish BhatnagarChief Executive OfficerNov 30 '23Sale28.6527,716794,116108,062Dec 04 08:02 PM
Mackaness James HChief Financial OfficerNov 30 '23Sale28.654,186119,93721,303Dec 04 08:04 PM
Yen KristenSee RemarksNov 30 '23Sale28.653,963113,54721,950Dec 04 08:06 PM
Hirano Patricia CSee RemarksNov 30 '23Sale28.653,823109,53626,218Dec 04 08:03 PM
Anish BhatnagarChief Executive OfficerNov 29 '23Sale27.8327,827774,535135,778Nov 30 09:50 PM
Mackaness James HChief Financial OfficerNov 29 '23Sale27.834,203116,98625,489Nov 30 09:52 PM
Yen KristenSee RemarksNov 29 '23Sale27.833,979110,75125,913Nov 30 09:52 PM
Hirano Patricia CSee RemarksNov 29 '23Sale27.833,839106,85530,041Nov 30 09:51 PM
Anish BhatnagarChief Executive OfficerNov 28 '23Sale27.1225,678696,514163,605Nov 30 09:50 PM
Mackaness James HChief Financial OfficerNov 28 '23Sale27.123,878105,19029,692Nov 30 09:52 PM
Yen KristenSee RemarksNov 28 '23Sale27.123,67199,57529,892Nov 30 09:52 PM
Hirano Patricia CSee RemarksNov 28 '23Sale27.123,54296,07633,880Nov 30 09:51 PM
Anish BhatnagarChief Executive OfficerOct 20 '23Option Exercise3.169,64330,500198,926Dec 13 09:32 PM
Mackaness James HChief Financial OfficerOct 02 '23Option Exercise2.958,30924,49741,879Dec 13 09:32 PM
PERCEPTIVE ADVISORS LLC10% OwnerSep 28 '23Buy20.00250,0005,000,0003,074,542Sep 28 03:45 PM
PERCEPTIVE ADVISORS LLC10% OwnerSep 26 '23Buy16.40616,78910,113,9162,824,542Sep 28 03:45 PM